Abstract
We describe the first case of cutaneous infection caused by Chaetomium atrobrunneum and Clavispora lusitaniae in a one-and-a-half-year-old boy with acute and severe inflammation around his left eyelid. He presented to our outpatient center with a 6-day history and previously ineffective antibacterial therapy. Scanning electron microscopy (SEM) revealed hyphae and spores were on the surface of the crusty exudates and also penetrated into it, and the microbiology study further showed their characteristic cultural features. Fungal isolates were identified by the amplification and sequencing of the 26S RNA gene and of the ITS region, as C. lusitaniae and C. atrobrunneum. Up until now, most known clinical records of these rare species have shown them as agents of deep mycosis. Due to the emergency situation, medications were administered promptly and confirmed by subsequent fungal identification and successful therapeutic outcome. This article illustrates the importance of recognizing fungal infections, especially those caused by uncommon pathogens. Limitations in the routine identification procedures and therapeutic options of this emerging opportunistic agent are also discussed in this report.
Similar content being viewed by others
References
Rodrigues de Miranda L. Clavispora, a new yeast genus of the Saccharomycetales. Antonie van Leeuwenhoek. 1979;45:479–83.
Pappagianis D, Collins MS, Hector R, Remington J. Development of resistance to amphotericin B in Candida lusitaniae infecting a human. Antimicrob Agents Chemother. 1979;16:123–6.
Dick JD, Merz WG, Saral R. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob Agents Chemother. 1980;18:158–63.
Hadfield TL, Smith MB, Winn RE, Rinaldi MG, Guerra C. Mycoses caused by Candida lusitaniae. Rev Infect Dis. 1987;9:1006–12.
Merz WG. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J Clin Microbiol. 1984;20:1194–5.
Merz WG, Sandford GR. Isolation and characterization of a polyene-resistant variant of Candida tropicalis. J Clin Microbiol. 1979;9:677–80.
Passarelli N, Miranda MP, Castro C. A study of the incidence of air-borne fungi in the city of Rio de Janeiro. Ann Allergy. 1949;7:334–8.
Guarro J, Soler L, Rinaldi MG. Pathogenicity and antifungal susceptibility of Chaetomium species. Eur J Clin Microbiol Infect Dis. 1995;14:613–8.
Abbott SP, Sigler L, McAleer R, et al. Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium. J Clin Microbiol. 1995;33:2692–8.
Barron MA, Sutton DA, Veve R, et al. Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis. J Clin Microbiol. 2003;41:5302–7.
De Hoog GS, Guarro J, Gene′ J, Figueras MJ. Atlas of clinical fungi. 2nd ed. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands, Universitat Rovira i Virgili, Reus, Spain, 2000: 263–264.
Ran Y, He X, Zhang H, et al. Seborrheic dermatitis flare in a Dutch male due to commensal Malassezia furfur overgrowth. Med Mycol. 2008;46:611–4.
Zhang H, Ran Y, Liu Y, et al. Arthroderma vanbreuseghemii infection in three family members with kerion and tinea corporis. Med Mycol. 2009;47:539–44.
Vartivarian SE, Anaissie EJ, Bodey GP. Emerging fungal pathogens in immunocompromised patients: classification, diagnosis, and management. Clin Infect Dis. 1993;17:S487–91.
Viudes A, Peman J, Canton E, et al. Two cases of fungemia due to Candida lusitaniae and a literature review. Eur J Clin Microbiol Infect Dis. 2002;21:294–9.
Blinkhorn RJ, Adelstein D, Spagnuolo PJ. Emergence of a new opportunistic pathogen, Candida lusitaniae. J Clin Microbiol. 1989;27:236–40.
Nguyen MH, Morris AJ, Dobson ME, et al. Candida lusitaniae: an important emerging cause of candidemia. Infect Dis Clin Pract. 1996;5:273–8.
Ahearn DG, McGlohn MS. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole. J Clin Microbiol. 1984;19:412–6.
Krcmery VJ, Oravcova E, Spanic S, et al. Nosocomial breakthrough fungemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of etiology, risk factors, and outcome. J Antimicrob Chemother. 1998;41:373–80.
Cinar S, Nedret Koc A, Taskapan H, Dogukan A, Tokgoz B, Utas C. Case report: Candida lusitaniae peritonitis in a patient on continuous ambulatory peritoneal dialysis. Mycoses. 2002;45:120–2.
Nancy FC, Michael B. Candida lusitaniae meningitis. Infect Dis Clin Pract. 2007;15:359–63.
Yeghen T, Fenelon L, Campbell CK, et al. Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol. 1996;49:184–6.
Rinaldi MG, Inderlied CB, Mahnovski V, et al. Fatal Chaetomium atrobrunneum Ames, 1949, systemic mycosis in a patient with acute lymphoblastic leukemia, abstract PS2.69. In: Abstracts of the XI congress of the international society for human and animal mycology. 1991. Montreal, p. 107.
Krcmery V Jr, Mateicka F, Grausova S, Kunova A, Hanzen J. Invasive infections due to Clavispora lusitaniae. FEMS Immunol Med Microbiol. 1999;23:75–8.
Sanchez PJ, Cooper BH. Candida lusitaniae: sepsis and meningitis in a neonate. Pediatr Infect Dis J. 1987;6:758–9.
Yinnon AM, Woodin KA, Powell KR. Candida lusitaniae infection in the newborn: case report and review of the literature. Pediatr Infect Dis J. 1992;11:878–80.
Hawkins JL, Baddour LM. Candida lusitaniae infections in the era of fluconazole availability. Clin Infect Dis. 2003;36:e14–8.
Guppy KH, Thomas C, Thomas K, Anderson D. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen—Chaetomium atrobrunneum: case report. Neurosurgery. 1998;43:1463–9.
Segal R, Kusne S. Cerebral fungal infections in the immunocompromised host: a literature review and a new pathogen—Chaetomium atrobrunneum: case report. Neurosurgery. 1999;45:200.
Thomas C, Mileusnic D, Carey RB, Kampert M, Anderson D. Fatal Chaetomium cerebritis in a bone marrow transplant patient. Hum Pathol. 1999;30:874–9.
Ryder NS, Wagner S, Leitner I. In vitro activities of terbinafine against cutaneous isolates of Candida albicans and other pathogenic yeasts. Antimicrob Agents Chemother. 1998;42:1057–61.
Anandi V, John TJ, Walter A, et al. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol. 1989;27:2226–9.
Falcón CS, Falcón Mdel M, Ceballos JD, Florencio VD, Erchiga VC, Ortega SS. Onychomycosis by Chaetomium spp. Mycoses. 2009;52:77–9.
Serena C, Ortoneda M, Capilla J, et al. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother. 2003;47:3161–4.
Smith MR, Ryu SH, Suh PG, Rhee SG, Kung HF. S-phase induction and transformation of quiescent NIH 3T3 cells by microinjection of phospholipase C. Proc Natl Acad Sci U S A. 1989;86:3659–63.
Acknowledgments
This work was supported by Project 30570095 of National Natural Science Foundation of China.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zhang, H., Ran, Y., Li, D. et al. Clavispora lusitaniae and Chaetomium atrobrunneum as Rare Agents of Cutaneous Infection. Mycopathologia 169, 373–380 (2010). https://doi.org/10.1007/s11046-009-9266-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-009-9266-9